TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SLN

Silence Therapeutics PLC

Healthcare · Biotechnology

10.60$ -0.7% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Silence Therapeutics PLC (SLN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 106 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SLN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
98 119 245 189 169 162 185 165 147 131 115 106
88 103 229 176 158 150 170 149 134 119 103 94
59 69 143 109 62 97 65 42 82 11 5.7 72
59 69 193 150 129 118 137 114 102 85 70 72
0.5 24 24 1.7 0.3 0.8 17 20 22 25 22 9.3
0.0 -19 – – – – – – – – – –
7.8 10.0 9.8 7.7 7.5 7.5 9.8 11 11 11 10 10
0.3 0.4 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.2
78 97 89 76 75 55 298 71 73 69 66 68
18 22 18 18 17 13 19 15 17 14 10 13
0.2 0.2 0.2 0.2 0.1 0.1 0.1 – 0.1 0.1 0.1 0.1
12 3.3 13 15 14 3.0 19 14 17 4.4 10 13
20 22 156 113 95 107 -113 94 74 62 49 38
-291 -432 -386 -320 -347 -379 503 -530 -551 -563 -578 -590
12 13 15 16 16 16 16 16 16 16 16 16

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?